Alış
Interesting chart, possible breakout

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA.
Please note:
- I'm just sharing my view. its not a recommendation for buying or selling.
Please note:
- I'm just sharing my view. its not a recommendation for buying or selling.
“The fact is that if traders really believed that anything could happen at any time, there would be considerably fewer losers and more consistent winners.”
― Mark Douglas, Trading in the Zone
― Mark Douglas, Trading in the Zone
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.
“The fact is that if traders really believed that anything could happen at any time, there would be considerably fewer losers and more consistent winners.”
― Mark Douglas, Trading in the Zone
― Mark Douglas, Trading in the Zone
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.